Adaptive Announces IVDR Certification for clonoSEQ® in European Union
Adaptive Biotechnologies clonoSEQ is the first IVDR-certified test to detect minimal residual disease in patients with lymphoid malignancies SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biote...